The doctor is available 24 / 7 including direct phone access and direct e-mailing
Grosse: nothing to disclose, Johanna Ernst: nothing to disclose Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.02 - GENETICS, OMICS AND BIOMARKERS P1056 - ESOC25-766 REGULATORY AUTOANTIBODIES AND CLINICAL OUTCOME AFTER ISCHEMIC STROKE (PROSCIS-B) Anna-Sophia Miesenberger 1,2 , Pia Sophie Sperber 1,2,3 , Friederike Antonia Arlt 2,4 , Pimrapat Gebert 5 , Harald Heidecke 6 , Guido Moll 7,8,9 , Rusan Ali Catar 7 , Leif Koschtzke 1,2 , Christoph Harms 1,2 , Anna Kufner 1,2 , Thomas Liman 1,2,4 , Matthias Endres 1,2,4 1 Center for Stroke Research Berlin (CSB), Berlin, Charit - Universittsmedizin Berlin, corporate member of Freie Universitt Berlin and Humboldt-Universitt zu Berlin, Berlin, Germany, 2 Department of Neurology and Experimental Neurology, Charit-Universittsmedizin Berlin, Corporate Member of Freie Universitt Berlin, Humboldt-Universitt Berlin, Berlin, Germany, 3 Experimental and Clinical Research Center, a Cooperation Between Max Delbrck Center for Molecular Medicine in the Helmholtz Association, Charit Universittsmedizin Berlin, Geschftsfhrung, Charitplatz 1, 10117 Berlin, Germany, Berlin, Germany, 4 German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany, 5 Institute of Biometry and Clinical Epidemiology, Charit-Universittsmedizin Berlin, Corporate member of Freie Universitt and Humboldt-Universitt zu Berlin, Berlin, Germany, 6 CellTrend GmBH, Luckenwalde, Germany, 7 Department of Nephrology and Internal Intensive Care Medicine, Charit-Universittsmedizin Berlin, Corporate member of Freie Universitt and Humboldt-Universitt zu Berlin, Berlin, Germany, 8 BIH Center for Regenerative Therapies (BCRT), Berlin, Germany, 9 Julius Wolff Institute for Musculoskeletal Research (JWI), Berlin, Germany Background and Aims: The relevance of GPCR-directed regulatory autoantibodies (RABs) in stroke is unclear
People taking newer selective 5-HT3 receptor antagonists, such as ondansetron or granisetron, for nausea treatment are less likely to have restless legs syndrome diagnosed because these drugs do not bind to dopamine receptors
175 Brain stimulation Non-invasive brain stimulation is a relatively recent treatment option that has shown hope in the treatment of ASD
